Cytek Biosciences, Inc.
CTKBNasdaqCIK 1831915TechnologyFiscal year ends Dec 31
Reports and events: 81 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2916:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-407330 |
| 2026-08-2406:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-361705 |
| 2026-08-0517:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053496 |
| 2026-08-0516:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335212 |
| 2026-07-1516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-304789 |
| 2026-06-2516:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-282871 |
| 2026-06-1616:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-272582 |
| 2026-06-0216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-253538 |
| 2026-05-0717:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032293 |
| 2026-05-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211948 |
| 2026-04-2816:35 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001140361-26-017479 |
| 2026-02-2616:37 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012352 |
| 2026-02-2616:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076768 |
| 2026-01-1316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-011748 |
| 2025-11-0517:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049697 |
| 2025-11-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266973 |
| 2025-08-0617:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038422 |
| 2025-08-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174459 |
| 2025-06-2416:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-145725 |
| 2025-05-0817:21 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023927 |
| 2025-05-0816:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-115965 |
| 2025-04-2816:18 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001140361-25-016032 |
| 2025-02-2817:35 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008780 |
| 2025-02-2716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-039225 |
| 2025-01-1508:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-006599 |
| 2024-11-0717:38 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045834 |
| 2024-11-0516:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-251268 |
| 2024-09-1206:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-217558 |
| 2024-08-0617:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035264 |
| 2024-08-0616:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-194907 |
| 2024-06-1116:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-159094 |
| 2024-05-0816:35 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021723 |
| 2024-05-0816:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134238 |
| 2024-04-2516:23 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001140361-24-022063 |
| 2024-03-1917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-071467 |
| 2024-03-1316:42 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-010933 |
| 2024-03-0106:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-054312 |
| 2024-02-2706:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-046891 |
| 2024-01-0906:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-004805 |
| 2023-11-2807:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-283662 |
| 2023-11-1416:39 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-038974 |
| 2023-11-0906:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-274005 |
| 2023-11-0716:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-272504 |
| 2023-09-1917:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-101999 |
| 2023-08-0816:34 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039899 |
| 2023-08-0816:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-206235 |
| 2023-06-2006:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-169513 |
| 2023-05-1516:03 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-23-144952 |
| 2023-05-0916:38 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019777 |
| 2023-05-0916:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-139445 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.